Age at menopause and risk of sarcopenia in postmenopausal women: evidence from the China health and retirement longitudinal study

BACKGROUND: Menopausal age is closely associated with women's health, but research on its association with sarcopenia risk remains insufficient. Our study aimed to explore how menopausal age affects the risk of sarcopenia in postmenopausal women. METHODS: Based on the China Health and Retirement Longitudinal Study (CHARLS) database, we included 3,410 postmenopausal women from 2011-2015. Participants were divided into five groups according to menopausal age: premature menopause (< 40 years), early menopause (40-44 years), intermediate menopause (45-49 years), normal menopause (50-55 years), and late menopause (> 55 years). Sarcopenia was identified using the 2019 Asian Working Group for Sarcopenia (AWGS 2019) criteria. Mixed-effects logistic regression models were used to analyze the association between menopausal age and sarcopenia. RESULTS: The study included 3,410 postmenopausal women with a mean age of 64.39 ± 8.68 years and overall sarcopenia prevalence of 35.40%. Compared to the average age at menopause group (50-55 years; 1,593/3,410; 46.70%), premature menopause (127/3,410; 3.70%), early menopause (385/3,410; 11.30%), intermediate menopause (1,098/3,410; 32.20%), and late menopause (207/3,410; 6.10%) were all associated with increased sarcopenia risk. Compared to normal menopause (50-55 years), early menopause (40-44 years), intermediate menopause (45-49 years), and late menopause (> 55 years) were associated with statistically significant increased sarcopenia risk, while premature menopause (< 40 years) showed a non-significant elevated risk (OR = 1.40, 95% CI: 0.89-2.21, p = 0.1438). This association was stronger among women with late menarche, rural residence, married status, non-retirement, or low education levels. CONCLUSIONS: Both earlier and later than average menopausal age may be associated with increased sarcopenia risk in Chinese postmenopausal women, although the association for premature menopause did not reach statistical significance in fully adjusted models.

Authors

Institutions

Publication Details

Journal
Reproductive Health
Published
2026-05-18
DOI
https://doi.org/10.1186/s12978-026-02358-1
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Age at menopause and risk of sarcopenia in postmenopausal women: evidence from the China health and retirement longitudinal study

Yachai Li, Liang Qin, Nan Jia, Li Li et al.
Reproductive Health
Menopause: Health Impacts and Treatments
article

Age at menopause and risk of sarcopenia in postmenopausal women: evidence from the China health and retirement longitudinal study

Yachai Li, Liang Qin, Nan Jia, Li Li, Shentai Li, Yan Wang
article en

Abstract

BACKGROUND: Menopausal age is closely associated with women's health, but research on its association with sarcopenia risk remains insufficient. Our study aimed to explore how menopausal age affects the risk of sarcopenia in postmenopausal women. METHODS: Based on the China Health and Retirement Longitudinal Study (CHARLS) database, we included 3,410 postmenopausal women from 2011-2015. Participants were divided into five groups according to menopausal age: premature menopause (< 40 years), early menopause (40-44 years), intermediate menopause (45-49 years), normal menopause (50-55 years), and late menopause (> 55 years). Sarcopenia was identified using the 2019 Asian Working Group for Sarcopenia (AWGS 2019) criteria. Mixed-effects logistic regression models were used to analyze the association between menopausal age and sarcopenia. RESULTS: The study included 3,410 postmenopausal women with a mean age of 64.39 ± 8.68 years and overall sarcopenia prevalence of 35.40%. Compared to the average age at menopause group (50-55 years; 1,593/3,410; 46.70%), premature menopause (127/3,410; 3.70%), early menopause (385/3,410; 11.30%), intermediate menopause (1,098/3,410; 32.20%), and late menopause (207/3,410; 6.10%) were all associated with increased sarcopenia risk. Compared to normal menopause (50-55 years), early menopause (40-44 years), intermediate menopause (45-49 years), and late menopause (> 55 years) were associated with statistically significant increased sarcopenia risk, while premature menopause (< 40 years) showed a non-significant elevated risk (OR = 1.40, 95% CI: 0.89-2.21, p = 0.1438). This association was stronger among women with late menarche, rural residence, married status, non-retirement, or low education levels. CONCLUSIONS: Both earlier and later than average menopausal age may be associated with increased sarcopenia risk in Chinese postmenopausal women, although the association for premature menopause did not reach statistical significance in fully adjusted models.

Reproductive Health
Hebei Medical University (CN), Second Hospital of Hebei Medical University (CN), Affiliated Hospital of Hebei University (CN)
Quality Education
Openalex Percentile: Top 6%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.